Early detection and personalized treatment are important tools in the fight against lung cancer. At Franciscan Health, our team of experts utilizes cross-specialty collaboration to ensure the best possible outcome.
Lung cancer is cancer that starts in the cells that make up the lungs. There are two primary types of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Identifying the type of lung cancer helps in determining the best approach to treatment. About 85% to 90% of lung cancer diagnoses are categorized as non-small cell lung cancer; there are three subcategories of NSCLC.
Only about 10% to 15% of lung cancer diagnoses are categorized as small cell lung cancer. It often metastasizes at a faster pace and earlier stage.
At Franciscan Health, our cross-specialty collaboration makes personalized treatment plans easy and accessible. Our team of experts in pulmonology, medical oncology, cardiothoracic surgery, pathology, and radiology are all in one convenient location, working in tandem with patients and their families toward the best possible outcome.
A cancer nurse navigator will guide patients on a one-on-one basis along the path from diagnosis through treatment such as cutting edge immunotherapy, targeted radiation therapy, chemotherapy, and access to the latest breakthrough clinical trials.
Lung cancer is often diagnosed based on symptoms; unfortunately, symptoms don’t typically occur until the disease is in a late stage and treatment options are limited. At Franciscan Health we promote early detection through the safe, simple, non-invasive lung CT screening program. There is a minimal amount of radiation exposure and a heart scan is included for free.
Talk to your Franciscan Health physician if you’re experiencing common lung cancer symptoms such as: